Explaining the Importance of Molecular Testing to Patients With NSCLC

Presented by

AONN

Sponsored by

AstraZeneca

The Academy of Oncology Nurse & Patient Navigators (AONN+) is pleased to introduce an educational video in which expert nurse navigators and nurse practitioners discuss how to explain the importance of molecular testing to patients with resectable or metastatic non-small cell lung cancer in a way that patients and caregivers can understand.

This video is part 3 of a 5-part educational video series we’ve produced in partnership with AstraZeneca. Topics of discussion in this video include:

  • How do you explain the importance of molecular testing to patients?
  • What are some of the challenges you see with molecular testing and how are you overcoming them?
  • How does your institution handle molecular testing in resectable non-small cell lung cancer?
  • How do you handle molecular testing in metastatic non-small cell lung cancer?
  • What do you most want community nurse navigators and nurse practitioners to know about molecular testing for patients with resectable and metastatic non-small cell lung cancer?

Benjamin Levy, MD

Associate Professor
Johns Hopkins School of Medicine
Clinical Director of Medical Oncology
Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial Hospital
Last modified: May 24, 2022

Subscribe Today!

To sign up for our print publication or e-newsletter, please enter your contact information below.

I'd like to receive:

  • First Name *
    Last Name *
     
     
    Profession or Role
    Primary Specialty or Disease State
    Country